Results 141 to 150 of about 3,398 (179)

Efficacy and safety of intravenous ferric carboxymaltose in the treatment of Restless Legs Syndrome: a systematic review and meta-analysis. [PDF]

Front Neurol
Khan A, Kumar H, Rai KD, Saeed A, Ishtiaq J, Tanveer Alam M, Chawla S, Haque MA.   +7 more
europepmc   +1 more source

Ferric Carboxymaltose as an Effective and Safe Alternative to Iron Sucrose for Treatment of Iron Deficiency Anemia during Pregnancy. [PDF]

J Mother Child
Singh A, Goyal M, Shekhar S, Singh P, Sharma P.   +4 more
europepmc   +1 more source

TRANSIENT HYPOPHOSPHATEMIA AS POSSIBLE ADVERSE OUTCOME AFTER IRON DEFICIENCY ANEMIA TREATMENT WITH FERRIC CARBOXYMALTOSE - SINGLE CENTER EXPERIENCE. [PDF]

Acta Clin Croat
Brkić N, Vučinić Ljubičić I, Holik H, Coha B.   +3 more
europepmc   +1 more source

Corrigendum to: Single Dose of Intravenous Ferric Carboxymaltose Prevents Anemia for 6 Months among Moderately or Severely Anemic Postpartum Women: A Case Study from India. Curr Dev Nutr. 2021; 5(7): nzab078. doi: 10.1093/cdn/nzab078. [PDF]

Curr Dev Nutr
Kaur R, Kant S, Haldar P, Ahamed F, Singh A, Dwarakanathan V, Malhotra S, Yadav K.   +7 more
europepmc   +1 more source

Low-dose ferric carboxymaltose vs. oral iron for improving hemoglobin levels in postpartum East Asian women: A randomized controlled trial. [PDF]

PLoS One
Nagao T, Takahashi K, Takahashi S, Yokomizo R, Samura O, Okamoto A.   +5 more
europepmc   +1 more source